Background Cardiovascular diseases are still the leading cause of death worldwide. Heart failure (HF) is now recognized as a major problem in industrialized countries. Short-term adjusted outcomes are indicators of the quality of the diagnostic and therapeutic process during/after hospitalization. The aim of the study is to evaluate the in-hospital mortality and hospital 30-day readmissions for heart failure using two different Risk Adjustment (RA) tools. Methods We used data from the hospital discharge abstract (HD) of a retrospective cohort of heart failure patients (2002-2007) admitted in Tuscan hospitals, in Italy. The outcomes considered were: in-hospital mortality and hospital read- mission at 30 days after discharge. We compare two R...
Objective: To identify factors associated with short term mortality in hospitalised patients with he...
BACKGROUND: Hospitalisation for heart failure is common and post-discharge outcomes, including readm...
Introduction: From a prospective multi-center multi-country clinical trial, we developed and validat...
Background Cardiovascular diseases are still the leading cause of death worldwide. Heart failure (HF...
Purpose Heart failure (HF) is recognized as a major problem in industrialized countries. Short-term...
Purpose: Heart failure (HF) is recognized as a major problem in industrialized countries. Short-term...
Background: Hospital discharge records (HDRs) are routinely used to assess outcomes of care and to c...
Aims: In patients with acute heart failure (AHF), early worsening heart failure (WHF) predicts a...
In patients with acute heart failure (AHF), early worsening heart failure (WHF) predicts a significa...
Congestive heart failure (CHF) constitutes an important public health problem in Italy, evidenced by...
Objectives: This study sought to review the literature for risk prediction models in patients wit...
Patients with acute heart failure (AHF) show various clinical courses during hospitalization. We aim...
BACKGROUND: Comparing heart failure (HF) outcomes across hospitals requires adequate risk adjustment...
Background: This study aimed to develop a risk prediction model (AUS-HF model) for 30-day all-cause ...
Background: Models for predicting the outcome of patients hospitalized for heart failure (HF) rarely...
Objective: To identify factors associated with short term mortality in hospitalised patients with he...
BACKGROUND: Hospitalisation for heart failure is common and post-discharge outcomes, including readm...
Introduction: From a prospective multi-center multi-country clinical trial, we developed and validat...
Background Cardiovascular diseases are still the leading cause of death worldwide. Heart failure (HF...
Purpose Heart failure (HF) is recognized as a major problem in industrialized countries. Short-term...
Purpose: Heart failure (HF) is recognized as a major problem in industrialized countries. Short-term...
Background: Hospital discharge records (HDRs) are routinely used to assess outcomes of care and to c...
Aims: In patients with acute heart failure (AHF), early worsening heart failure (WHF) predicts a...
In patients with acute heart failure (AHF), early worsening heart failure (WHF) predicts a significa...
Congestive heart failure (CHF) constitutes an important public health problem in Italy, evidenced by...
Objectives: This study sought to review the literature for risk prediction models in patients wit...
Patients with acute heart failure (AHF) show various clinical courses during hospitalization. We aim...
BACKGROUND: Comparing heart failure (HF) outcomes across hospitals requires adequate risk adjustment...
Background: This study aimed to develop a risk prediction model (AUS-HF model) for 30-day all-cause ...
Background: Models for predicting the outcome of patients hospitalized for heart failure (HF) rarely...
Objective: To identify factors associated with short term mortality in hospitalised patients with he...
BACKGROUND: Hospitalisation for heart failure is common and post-discharge outcomes, including readm...
Introduction: From a prospective multi-center multi-country clinical trial, we developed and validat...